The acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure in
critically ill patients and is defined by the acute onset of noncardiogenic pulmonary oedema …

Sepsis-induced acute respiratory distress syndrome (ARDS) has high morbidity and
mortality and arises after lung infection or infection at extrapulmonary sites. An aberrant host …

Rationale: Clinical and epidemiologic data in coronavirus disease (COVID-19) have
accrued rapidly since the outbreak, but few address the underlying pathophysiology …

Importance Platelets represent a potential therapeutic target for improved clinical outcomes
in patients with COVID-19. Objective To evaluate the benefits and risks of adding a P2Y12 …

Severe acute respiratory syndrome coronavirus 2 is responsible for coronavirus disease
2019 (COVID‐19). While COVID‐19 is often benign, a subset of patients develops severe …

Platelets are among the most abundant cells in the mammalian circulation. Classical platelet
functions in hemostasis and wound healing have been intensively explored and are …

Coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the new severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread around the world …

Lung inflammation, infection, and injury can lead to critical illness and death. The current
means to pharmacologically treat excessive uncontrolled lung inflammation needs …

Dysregulated leukocyte responses underlie the pathobiology of sepsis, which is a leading
cause of death. However, measures of leukocyte function are not routinely available in …

The uneven regulation of inflammation is related to various diseases, making anti-
inflammation a potential option for the development of novel therapies. In this study, we …